FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: NASDAQ:SVNT

Sort
E.g., 2013-06-18
E.g., 2013-06-18
Enter a comma separated list of user names.

Amicus Therapeutics, Inc. (Nasdaq:FOLD) and GlaxoSmithKline (GSK) announced that the first patient has commenced dosing in a Phase 3 global registration study (Study 012) to compare the safety and efficacy of Amigal(TM) (migalastat HCl) and enzyme replacement therapy (ERT) for the treatment of Fabry disease.

GreenHouse Holdings, Inc. (GRHU)

GreenHouse Holdings, Inc. (GRHU) company designs, engineers and installs disparate products and technologies that enable its clients to reduce their energy costs and carbon footprint.

Eline Entertainment Group, Inc. (EEGI.PK) announced that the company has entered into merger discussions with China-based video game designer Vu365. EEGI (www.elineentertainment.com) management feels that this is a significant event that merits reporting to the market.

Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) recently announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA(TM) (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy.

ADVERTISE WITH US